Specific gene delivery to liver sinusoidal and artery endothelial cells
- 19 September 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 122 (12), 2030-2038
- https://doi.org/10.1182/blood-2012-11-468579
Abstract
Key Points CD105-mediated cell entry using targeted lentiviral vectors leads to specific gene transfer of LSEC upon systemic administration.Keywords
This publication has 43 references indexed in Scilit:
- In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated NanographeneACS Nano, 2012
- Rapid and Efficient Clearance of Blood-borne Virus by Liver Sinusoidal EndotheliumPLoS Pathogens, 2011
- DARPins: An Efficient Targeting Domain for Lentiviral VectorsMolecular Therapy, 2011
- Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis softwareBioinformatics, 2011
- Redirecting Lentiviral Vectors Pseudotyped with Sindbis Virus-Derived Envelope Proteins to DC-SIGN by Modification of N-Linked Glycans of Envelope ProteinsJournal of Virology, 2010
- In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic toleranceBlood, 2009
- A versatile targeting system with lentiviral vectors bearing the biotin‐adaptor peptideThe Journal of Gene Medicine, 2009
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the LiverPhysiological Reviews, 2008
- Targeting lentiviral vectors to specific cell types in vivoProceedings of the National Academy of Sciences of the United States of America, 2006
- Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglinEuropean Journal of Cancer, 2000